Publication | Open Access

Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on B cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma

Immunotherapy ResponseOncologySingle Cell SequencingBulk Rna-sequencing IdentifiesMedicineLung AdenocarcinomaImmunologyPathologyCancer GenomicsBronchial NeoplasmSingle-cell AnalysisMolecular DiagnosticsTumor MicroenvironmentLung Cancer